✦ LIBER ✦

Efficacy and tolerability of docetaxel as second line treatment in patients with non-small cell lung cancer: an experience in three centres

✍ Scribed by Micallef, R.A.; Birch, E.; Baker, J.; Brewster, A.; Hanna, L.; Lester, J.F.; Linnane, S.J.; Macbeth, F.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and mitomycin as second-line t

✍ J. Feliu; G. Martín; J. Castro; A. Sundlov; A. Rodriguez-Jaráiz; E. Casado; M. L 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 209 KB

P-20 Docetaxel and gemcitabine as second

✍ Bernardo, Maria Manuela; Sousa, Manuel; Nunes, Orlando; Gonçalves, Antonio; Mato 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Docetaxel and carboplatin combination as

✍ J.W.G. Van Putten; F.M. Wachters; H.J.M. Groen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

6619 POSTER Efficacy of weekly docetaxel

✍ Lee, W.S.; Bae, B.J.; Ryoo, H.M.; Bae, S.H.; Lee, S.C.; Hyun, D.S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Cisplatin and irinotecan (CPT-11) as sec

✍ Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB